Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

Intermediate-risk Patients Have Similar Five-year Outcomes With Transcatheter or Surgical Aortic Valve Replacement
November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality or stroke between patients at intermediate surgical risk who had transcatheter ...
Most Popular Cardiology Technology Content in September 2021
October 6, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September 2021. This is based on the website’s ...
First Woman in World Receives New Type of Artificial Heart
September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed the world’s first Carmat Aeson bioprosthetic total artificial heart ...
Medtronic Ends Sales of HVAD Ventricular Assist System
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). On June 3, the company notified physicians to cease new ...

News | Cardiovascular Surgery

Novel Surgical Device Can Potentially Improve Outcomes of Coronary Bypass Grafting That Uses Leg Veins

November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...

November 23, 2021

News | Cardiovascular Surgery

Improved Outcomes and Decreased Mortality in Aortic Dissections Achieved Using Care Plans Designed by Multidisciplinary Expertise

November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...

November 22, 2021

Coronary Artery Bypass Grafting (CABG). #AHA21

News | Cardiovascular Surgery

Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A in Patients Undergoing CABG

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

November 18, 2021

Repair of Tricuspid Valve Leak CTCR-MVS - Evaluating the Benefit of Concomitant Tricuspid Repair During Mitral Valve Surgery.

News | Structural Heart

Repair of Tricuspid Valve Leak During Mitral Valve Surgery May Benefit Some Adults

November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may ...

November 18, 2021

Cardiovascular Surgery Ticagrelor - significant increase in bleeding when people had bypass surgery after two to three days of discontinuing ticagrelor. #AHA #AHA21

News | Cardiovascular Surgery

Time From Stopping Blood Thinner To Bypass Surgery May Be Shortened for Select Patients

November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may ...

November 18, 2021

News | Structural Heart

Surgery to Replace Heart Valve Beneficial Even With No Symptoms of Severe Aortic Stenosis

November 17, 2021 — For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief ...

November 17, 2021

$Abbott's fractional flow reserve (FFR) system. #TCT #TCT21 #FAME3$

News | FFR Technologies

FAME 3 Study Finds FFR Guided PCI Did Not Perform as Well at One-year Compared to Bypass Surgery

November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...

November 09, 2021

TAVR CT image reconstruction of an implanted Medtronic CoreValve. #TCT21 #TCT #TAVR #SURTAVI

News | Heart Valve Technology

Intermediate-risk Patients Have Similar Five-year Outcomes With Transcatheter or Surgical Aortic Valve Replacement

November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality ...

November 09, 2021

A PARTNER 3 trial economic analysis shows for low surgical risk patients, TAVR is cost-saving compared with SAVR. TAVR Sapien Valve visualized using a GE guidance software. #TCT2021

News | Structural Heart

TAVR Is Cost Effective Compared With Surgical Replacement for Low-risk Patients

November 9, 2021 — An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve ...

November 09, 2021

QuickClot already has an FDA-cleared product for use for vascular access hemostasis management in cath lab procedures. The hemostatic technology consists of a non-woven material impregnated with kaolin, an inorganic mineral. When kaolin contacts blood it activates Factor XII, which accelerates the body’s natural clotting cascade.

News | Hemostasis Management

Teleflex Completes Enrollment in IDE Study of QuickClot in Cardiac Surgery

October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the ...

October 27, 2021

Two of the top technology headlines this past month was the FDA clearance of the Abbott Portico transcatheter aortic valve replacement (TAVR) device, and the first women to receive a Carmat artificial heart.

Feature | BY Dave Fornell, DAIC Editor

October 6, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

October 06, 2021

Cardiothoracic surgeons with UofL Health – Jewish Hospital and the University of Louisville performed the world’s first Carmat Aeson bioprosthetic total artificial heart implantation in a female patient on Sept. 14, 2021. The device was small enough to fit into the woman's smaller chest cavity. The device is being tested as a bridge to heart transplant rather than use of a LVAD. Photo by UofL Health.

News | Heart Failure

First Woman in World Receives New Type of Artificial Heart

September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed ...

September 22, 2021

emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS). #HRS21 #HRS2021

News | EP Lab

Spinal Cord Stimulation Helps Suppress AF in CABG Patients

August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation ...

August 03, 2021

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.

Feature | Ventricular Assist Devices (VAD) | By Dave Fornell, Editor

Medtronic Ends Sales of HVAD Ventricular Assist System

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular ...

July 08, 2021

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be thwarted by infection. No matter how skilled a cardiac surgeon or how successful a surgery, when an SSI sets in, patients can find themselves fighting for their lives. While not unique to cardiovascular surgery, post-operative infections have severe repercussions for recovering heart surgery patients. Unfortunately, even with SSI prevention methods implemented, SSIs remain as common as 5% in car

Feature | Cardiovascular Surgery | By Noam Emanuel, Ph.D.

Rethinking Heart Surgery Surgical Site Infection Prevention

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be ...

June 24, 2021